Published in Br J Pharmacol on January 01, 1980
Comparison of the actions of U-46619, a prostaglandin H2-analogue, with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparations. Br J Pharmacol (1981) 2.79
The classification of prostaglandin DP-receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist. Br J Pharmacol (1989) 2.09
Metabolites of arachidonic acid formed by human gastrointestinal tissues and their actions on the muscle layers. Br J Pharmacol (1981) 1.21
Antagonism of prostanoid-induced contractions of rat gastric fundus muscle by SC-19220, sodium meclofenamate, indomethacin or trimethoquinol. Br J Pharmacol (1980) 0.90
Pinane thromboxane A2 analogues are non-selective prostanoid antagonists in rat and human stomach muscle. Br J Pharmacol (1982) 0.85
Changes in cardiovascular sensitivity of alloxan-treated diabetic rats to arachidonic acid. Br J Pharmacol (1986) 0.85
Pharmacological effects of (+/-)-11-deoxy, 16-phenoxy-prostaglandin E1 derivatives in the cardiovascular system. Br J Pharmacol (1985) 0.83
A molecular mechanism for signaling between seven-transmembrane receptors: evidence for a redistribution of G proteins. Proc Natl Acad Sci U S A (1998) 0.79
A comparative study of the prostanoid receptor profile of 9 alpha 11 beta-prostaglandin F2 and prostaglandin D2. Br J Pharmacol (1991) 0.79
Kinetic studies on stereospecific recognition by the thromboxane A2/prostaglandin H2 receptor of the antagonist, S-145. Br J Pharmacol (1991) 0.78
Effect of gender on development and diurnal rhythm of prostaglandin receptors in rat aorta. Br J Pharmacol (1981) 0.77
Effect of endothelium removal on stimulatory and inhibitory modulation of rat aortic prostacyclin synthesis. Br J Pharmacol (1989) 0.77
Evidence against the involvement of prostaglandins in the vasoconstrictor action of calcium ion in rat mesenteric blood vessels. Br J Pharmacol (1981) 0.75
A sensitive method for the assay of 5-hydroxytryptamine. Br J Pharmacol Chemother (1957) 17.22
Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci U S A (1975) 10.82
THE USE OF ISOLATED ORGANS FOR DETECTING ACTIVE SUBSTANCES IN THE CIRCULATING BLOOD. Br J Pharmacol Chemother (1964) 9.77
Reactions of strips of rabbit aorta to epinephrine, isopropylarterenol, sodium nitrite and other drugs. J Pharmacol Exp Ther (1953) 8.48
Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac ateries and inhibits platelet aggregation. Prostaglandins (1976) 4.54
Receptors for 5-hydroxytryptamine and noradrenaline in rabbit isolated ear artery and aorta. Br J Pharmacol (1976) 3.95
The cat lung strip as an in vitro preparation of peripheral airways: a comparison of beta-adrenoceptor agonists, autacoids and anaphylactic challenge on the lung strip and trachea. Br J Pharmacol (1976) 3.04
Imidazole: a selective inhibitor of thromboxane synthetase. Prostaglandins (1977) 2.48
A COMPARISON OF THE ACTIONS OF PROSTAGLANDINS F2-ALPHA AND E1 ON SMOOTH MUSCLE. Br J Pharmacol Chemother (1965) 2.22
Some biological effects of prostaglandin endoperoxide analogs. Life Sci (1976) 1.40
Prostaglandins H1 and H2. Convenient biochemical synthesis and isolation. Further biological and spectroscopic characterization. Prostaglandins (1977) 1.40
The effects of uptake1 on alpha-adrenoceptor antagonist potency in dog saphenous vein. Br J Pharmacol (1978) 1.19
Activity of prostaglandin E, F, A and B on sphincter, dilator and ciliary muscle preparations of the cat eye. Prostaglandins (1975) 1.10
X. International Union of Pharmacology recommendations for nomenclature of new receptor subtypes. Pharmacol Rev (1996) 13.17
International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol Rev (1994) 7.11
Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology (1986) 5.83
The case for allowing kidney sales. International Forum for Transplant Ethics. Lancet (1998) 5.25
Pharmacology of AH 5158; a drug which blocks both - and -adrenoceptors. Br J Pharmacol (1972) 4.53
Should organs from patients in permanent vegetative state be used for transplantation? International Forum for Transplant Ethics. Lancet (1997) 4.04
Receptors for 5-hydroxytryptamine and noradrenaline in rabbit isolated ear artery and aorta. Br J Pharmacol (1976) 3.95
Salbutamol: a new, selective beta-adrenoceptive receptor stimulant. Br J Pharmacol (1969) 3.86
Glycogen storage disease in adults. Ann Intern Med (1994) 3.58
ATP is released from rabbit urinary bladder epithelial cells by hydrostatic pressure changes--a possible sensory mechanism? J Physiol (1997) 3.43
International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol Rev (2001) 3.26
Enzymes of glycerolipid synthesis in eukaryotes. Annu Rev Biochem (1980) 3.06
A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug. Br J Clin Pharmacol (1976) 2.82
Immunocytochemical localization of phytochrome. Proc Natl Acad Sci U S A (1971) 2.81
Comparison of the actions of U-46619, a prostaglandin H2-analogue, with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparations. Br J Pharmacol (1981) 2.79
Studies on the characterisation of prostanoid receptors: a proposed classification. Prostaglandins (1982) 2.73
A new preparation of the isolated intact trachea of the guinea-pig. J Pharm Pharmacol (1970) 2.58
AMP-activated kinase reciprocally regulates triacylglycerol synthesis and fatty acid oxidation in liver and muscle: evidence that sn-glycerol-3-phosphate acyltransferase is a novel target. Biochem J (1999) 2.46
Salmeterol, a novel, long-acting beta 2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo. Br J Pharmacol (1991) 2.41
GR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro. Br J Pharmacol (1989) 2.39
Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: a randomized, placebo-controlled trial. Protocol 18 Aredia Breast Cancer Study Group. J Clin Oncol (1999) 2.29
Comparison of the bronchodilator and cardiovascular actions of salbutamol, isoprenaline and orciprenaline in guinea-pigs and dogs. Br J Pharmacol (1971) 2.27
An immunochemical characterization of the phytochrome destruction reaction. Biochim Biophys Acta (1974) 2.20
A comparison of 5-hydroxytryptamine receptors mediating contraction in rabbit aorta and dog saphenous vein: evidence for different receptor types obtained by use of selective agonists and antagonists. Br J Pharmacol (1985) 2.06
Analysis of amino acid motifs diagnostic for the sn-glycerol-3-phosphate acyltransferase reaction. Biochemistry (1999) 2.04
Reversible redistribution of phytochrome within the cell upon conversion to its physiologically active form. Proc Natl Acad Sci U S A (1975) 2.01
A non-adrenergic inhibitory nervous pathway in guinea-pig trachea. Br J Pharmacol (1974) 1.97
The inducement of tone and its inhibition in isolated tracheal muscle. J Pharm Pharmacol (1971) 1.95
Classification and nomenclature of somatostatin receptors. Trends Pharmacol Sci (1995) 1.90
Selective changes in microsomal enzymes of triacylglycerol phosphatidylcholine, and phosphatidylethanolamine biosynthesis during differentiation of 3T3-L1 preadipocytes. J Biol Chem (1978) 1.86
Evidence for two types of excitatory receptor for 5-hydroxytryptamine in dog isolated vasculature. Br J Pharmacol (1980) 1.86
AH6809, a prostaglandin DP-receptor blocking drug on human platelets. Br J Pharmacol (1988) 1.82
Electrophysiological properties of P2X-purinoceptors in rat superior cervical, nodose and guinea-pig coeliac neurones. J Physiol (1995) 1.79
Effects of some purine derivatives on the guinea-pig trachea and their interaction with drugs that block adenosine uptake. Br J Pharmacol (1976) 1.77
Genome of infectious bronchitis virus. J Virol (1977) 1.74
Combined alpha- and beta-adrenoceptor blocking drug AH 5158: further studies on alpha-adrenoceptor blockade in anaesthetized animals. Br J Pharmacol (1975) 1.72
Two types of excitatory receptor for 5-hydroxytryptamine in dog vasculature? [proceedings]. Br J Pharmacol (1977) 1.67
GR113808: a novel, selective antagonist with high affinity at the 5-HT4 receptor. Br J Pharmacol (1994) 1.64
Acyl-CoA synthetase isoforms 1, 4, and 5 are present in different subcellular membranes in rat liver and can be inhibited independently. J Biol Chem (2001) 1.64
Expression and characterization of recombinant rat Acyl-CoA synthetases 1, 4, and 5. Selective inhibition by triacsin C and thiazolidinediones. J Biol Chem (2001) 1.64
AH23848: a thromboxane receptor-blocking drug that can clarify the pathophysiologic role of thromboxane A2. Circulation (1985) 1.63
Rationale for the use of 5-HT1-like agonists in the treatment of migraine. J Neurol (1991) 1.61
Leptin directly alters lipid partitioning in skeletal muscle. Diabetes (1997) 1.57
5-Hydroxytryptamine-induced relaxation of isolated mammalian smooth muscle. Eur J Pharmacol (1983) 1.55
5-Hydroxytryptamine contracts human coronary arteries predominantly via 5-HT2 receptor activation. Eur J Pharmacol (1989) 1.55
Ionic effects on human recombinant P2X7 receptor function. Naunyn Schmiedebergs Arch Pharmacol (1999) 1.52
Acylglycerol recycling from triacylglycerol to phospholipid, not lipase activity, is defective in neutral lipid storage disease fibroblasts. J Biol Chem (1996) 1.48
Electron microscopic localization of phytochrome in plants using an indirect antibody-labeling method. J Histochem Cytochem (1974) 1.47
Acute nociception mediated by hindpaw P2X receptor activation in the rat. Br J Pharmacol (1997) 1.46
Identification of putative 5-HT4 receptors in guinea-pig ascending colon. Eur J Pharmacol (1991) 1.46
Renal disease in type I glycogen storage disease. N Engl J Med (1988) 1.45
International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. IX. Recommendations on terms and symbols in quantitative pharmacology. Pharmacol Rev (1995) 1.45
Blockade of human P2X7 receptor function with a monoclonal antibody. Blood (1998) 1.45
Peripheral 5-hydroxytryptamine receptors and their classification. Neuropharmacology (1984) 1.43
"Selectivity" and "specificity": what do they mean? Gen Pharmacol (1993) 1.40
Inhibition of natural anti-inflammatory mechanism by beta 2-agonists. Lancet (1991) 1.40
Nodes in the neck. S Afr Med J (1996) 1.39
Foreign bodies and balloon catheters. Trop Doct (1996) 1.39
Further characterization of the 5-HT receptor mediating vascular relaxation and elevation of cyclic AMP in porcine isolated vena cava. Br J Pharmacol (1989) 1.39
A method for quantitating platelet aggregation and analyzing drug-receptor interactions on platelets in whole blood in vitro. J Pharmacol Methods (1981) 1.39
Triacsin C blocks de novo synthesis of glycerolipids and cholesterol esters but not recycling of fatty acid into phospholipid: evidence for functionally separate pools of acyl-CoA. Biochem J (1997) 1.39
The selective carotid arterial vasoconstrictor action of GR43175 in anaesthetized dogs. Br J Pharmacol (1989) 1.39
Receptors for 5-hydroxytryptamine: current perspectives on classification and nomenclature. Neuropharmacology (1994) 1.37
Lipid topogenesis. J Lipid Res (1981) 1.36
Functional characterization of three adenosine receptor types. Br J Pharmacol (1993) 1.35
New evidence with selective agonists and antagonists for the subclassification of PGE2-sensitive (EP) receptors. Adv Prostaglandin Thromboxane Leukot Res (1987) 1.35
Pharmacological characterization of ATP- and LPS-induced IL-1beta release in human monocytes. Br J Pharmacol (1999) 1.34
A comparison of the beta-adrenoreceptor stimulant properties of isoprenaline, with those of orciprenaline, salbutamol, soterenol and trimetoquinol on isolated atria and trachea of the guinea pig. J Pharm Pharmacol (1970) 1.34
The donation and transplantation of kidneys: should the law be changed? J Med Ethics (1979) 1.32
5-HT1-like receptors mediate 5-hydroxytryptamine-induced contraction of human isolated basilar artery. Br J Pharmacol (1989) 1.31
Properties of the pore-forming P2X7 purinoceptor in mouse NTW8 microglial cells. Br J Pharmacol (1997) 1.30
Naratriptan: biological profile in animal models relevant to migraine. Cephalalgia (1997) 1.30
A comparison of some cardiovascular properties of propranolol, MJ 1999 and quinidine in relation to their effects in hypertensive animals. Br J Pharmacol (1968) 1.29
P2X receptor-mediated excitation of nociceptive afferents in the normal and arthritic rat knee joint. Br J Pharmacol (1998) 1.29
Effects of antagonists at the human recombinant P2X7 receptor. Br J Pharmacol (1998) 1.28
Ketanserin--a novel antihypertensive drug? J Pharm Pharmacol (1982) 1.28
Neutral lipid storage disease with fatty liver and cholestasis. J Pediatr Gastroenterol Nutr (1997) 1.27
The selectivity of beta-adrenoceptor antagonists on cardiovascular and bronchodilator responses to isoprenaline in the anaesthetized dog. Br J Pharmacol (1975) 1.26
Mitochondrial glycerol phosphate acyltransferase directs the incorporation of exogenous fatty acids into triacylglycerol. J Biol Chem (2001) 1.26
Characterisation of the prostanoid receptors mediating contraction of guinea-pig isolated trachea. Prostaglandins (1985) 1.26
Contractile and relaxant actions of prostaglandins on guinea-pig isolated trachea. Br J Pharmacol (1980) 1.25